The Recent Study Conducted by Market Research Future (MRFR), the Global Preclinical CRO Market Will Capture an Impressive Growth Rate During The Review Period (2019-2023).
PAREXEL International Corporation, IQVIA, Envigo, Charles River, ICON plc., Eurofins Scientific, Medpace, PRA Health Sciences (PRA) and others.
Preclinical CRO Market Global Overview:
The Global Preclinical CRO Market is estimated to be valued at USD 5,234.7 Million by 2024 and is expected to register a CAGR of 8.14% during the forecast period.
The toxicology testing segment is expected to lead the market and register a substantial CAGR to reach USD 2,476.28 Million by the end of 2024. Increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. However, the bioanalysis and drug metabolism and pharmacokinetics (DMPK) studies segment is projected to exhibit the highest CAGR of 8.96% from 2019 to 2024. New technological developments by various companies to provide better services to pharmaceutical companies is driving the growth of the segment.
Americas accounted for the largest market share of 40.7% in 2018, and the regional market is projected to register a CAGR of 7.49% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 9.44% during the forecast period of 2019 to 2024.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7274
Global Preclinical CRO Market – Segmentations
The global preclinical CRO market has been segmented on the basis of services, therapeutic area, end user and region. On the basis of service, the market has been divided into the toxicology testing, bioanalysis & bioanalysis, and drug metabolism and pharmacokinetics (DMPK) studies and others. The toxicology segment held the majority market share in 2018. However, bioanalysis & bioanalysis and drug metabolism and pharmacokinetics (DMPK) studies are expected to be the fastest-growing owing to the new technological developments by various companies to provide better services to pharmaceutical companies.
Global Preclinical CRO Market – Regional Analysis
Geographically, the global preclinical CRO market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for the preclinical CRO in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing outsourcing activities in Europe are driving the growth of the preclinical CRO market in the region. Germany accounted for the largest market share of 24.7% in 2018, and the country-level market is projected to register a CAGR of 6.69% during the forecast period.
TOC:
1 Executive Summary$ 1,350.00
2 Market Introduction$ 0.00
3 Research Methodology$ 0.00
4 Market Dynamics$ 950.00
5 Market Factor Analysis$ 950.00
6 Global Preclinical CRO Market, By Service$ 1,650.00
7 Global Preclinical CRO Market, By Therapeutic Area$ 1,650.00
8 Global Preclinical CRO Market, By End User
Continued…
List of Tables:
TABLE 1 GLOBAL PRECLINICAL CRO MARKET, BY SERVICE, 2016–2024 (USD MILLION) 29
TABLE 2 GLOBAL PRECLINICAL CRO MARKET, FOR TOXICOLOGY TESTING, BY REGION, 2016–2024 (USD MILLION) 31
TABLE 3 GLOBAL PRECLINICAL CRO MARKET, FOR BIOANALYSIS AND DRUG METABOLISM AND PHARMACOKINETICS (DMPK) STUDIES, BY REGION, 2016–2024 (USD MILLION) 32
TABLE 4 GLOBAL PRECLINICAL CRO MARKET, FOR OTHERS, BY REGION, 2016–2024 (USD MILLION) 33
TABLE 5 GLOBAL PRECLINICAL CRO MARKET, BY THERAPEUTIC AREA, 2016–2024 (USD MILLION) 34
TABLE 6 GLOBAL PRECLINICAL CRO MARKET, FOR ONCOLOGY, BY REGION, 2016–2024 (USD MILLION) 36
TABLE 7 GLOBAL PRECLINICAL CRO MARKET, FOR CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, BY REGION, 2016–2024 (USD MILLION) 37
TABLE 8 GLOBAL PRECLINICAL CRO MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2016–2024 (USD MILLION) 38
TABLE 9 GLOBAL PRECLINICAL CRO MARKET, FOR IMMUNOLOGICAL DISORDERS, BY REGION, 2016–2024 (USD MILLION) 39
TABLE 10 GLOBAL PRECLINICAL CRO MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2016–2024 (USD MILLION) 40
Continued…
Browse more Information on this Report at https://www.marketresearchfuture.com/reports/preclinical-cro-market-7274
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
